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Human papillomaviruses (HPV) are small DNA tumor viruses. HPV infection requires entry of virions
into epithelial host cells that support the viral life cycle. Here, we used an in vivo mouse model, in
which HPV pseudoviruses (PVs) are scored for their ability to transduce reporter genes, to test the role
of various cellular proteins in entry. We initially investigated the role of integrin a6b4 in mediating
early steps of HPV infection. Deﬁciency of integrin a6b4 is modestly but signiﬁcantly suppressed
reporter-gene transduction by PVs in conditional integrin b4 knockout mice. We also investigated the
role of syndecan 1, a heparin sulfate proteoglycan (HSPG) for its role in HPV infection. We did not see a
signiﬁcant reduction in reporter-gene transduction by PVs in syndecan-1 null mice. This indicates that
this HSPG is not essential for early steps in HPV infection, but does not discount a need of other HSPGs
in mediating HPV infection.
& 2012 Elsevier Inc. All rights reserved.Introduction
Human papillomaviruses (HPVs) are the most common sexu-
ally transmitted (STD) pathogens. They mainly cause benign
lesions called papillomas or warts on skin and mucosa. Approxi-
mately a dozen mucosotropic HPV genotypes (the ‘high risk’
HPVs), including HPV16, are etiologically linked to the develop-
ment of multiple malignancies, such as cervical, vaginal, anal,
penile and a subset of head and neck cancers (zur Hausen, 2009).
In the currently held model for the HPV life cycle, HPVs enter cells
within the basal layer of stratiﬁed squamous epithelia at sites of
wounding, establish their genomes as nuclear plasmids in these
cells, and only upon differentiation of daughter cells, produce
progeny virus that are released into the environment to infect the
next host (Sapp and Bienkowska-Haba, 2009; Schiller et al., 2010).
Despite considerable research regarding the biology and onco-
genicity of HPVs, the earliest steps of HPV infection responsible
for the binding/entry of virus particles to the natural host cells,
their internalization and delivery of the HPV genomes to the host
nucleus are not yet well deﬁned. In this study, we examined the
cellular requirements for binding and entry.
The current literature on the cellular requirements for HPV
infection is confusing. Different proteins have been identiﬁed to
mediate HPV infection by different groups, including integrin a6b4
(Evander et al., 1997; McMillan et al., 1999) and its natural ligandll rights reserved.
).laminin 5 located in the extracellular matrix that forms the base-
ment membrane to which basal epithelial cells bind (Culp et al.,
2006a, 2006b, HSPGs on cell surface (Giroglou et al., 2001; Joyce
et al., 1999; Knappe et al., 2007; Shafti-Keramat et al., 2003;
Surviladze et al., 2012) and in extracellular matrix (Selinka et al.,
2007), as well as cyclophilins (Bienkowska-Haba et al., 2009, 2012).
While integrin a6b4 is debated as to its role in binding and entry of
HPVs, there has arisen equally inconclusive data regarding the role
of alternative cellular receptors in mediating HPV entry. Because
papillomaviral VLPs have long been known to bind to a broad range
of cell lines (Muller et al., 1995), this has led to the hypothesis that
papillomaviral receptors must be highly conserved in their expres-
sion amongst different cell types. Several laboratories have
described studies in tissue culture that support a role of HSPGs in
HPV infection. A fairly well conserved motif in the carboxyl region
of the major capsid protein, L1, which is conserved among different
HPV genotypes, is similar to known heparin binding motifs (Joyce
et al., 1999). HSPGs are reported in mediating entry of HPV16 L1/L2
and HPV33L1/L2 PVs in COS-7 and HeLa cells (Giroglou et al., 2001);
whereas, other studies refute a role of integrin a6b4 in entry of
HPV33L1/L2 PVs to these same cells (Selinka et al., 2002). The
amino acid residues of HPV16 L1 that mediate binding to HSPGs
have been further deﬁned (Knappe et al., 2007), and this binding
was found to cause a conformational change in L1 that exposes a
furin cleavage site in the minor capsid protein, L2, that was found to
be critical for infection (Richards et al., 2006). Carrageenan, a class
of sulfated polysaccharides extracted from algae, was found to
inhibit HPV PVs infections in vitro (Buck et al., 2006) and in vivo
(Roberts et al., 2007). Syndecan-1, a predominant HSPG in epithelial
Fig. 1. HPV16 infection in vivo in a dose dependent. Each group of mice reproductive
tracts (N¼6) were challenged with different amount of PVs (HPV16:LucF) as
indicated. An additional group of mice were challenged with 1Eþ07 PVs and 0.5%
carrageenan. 48 h after infection, mouse female reproductive tracts were harvested,
protein lysates made, and luciferase assays were carried out to quantify the
infectivity. Concentrations of total proteins were measure by Bradford protein assay.
The infectivity level (relative luminescence units, RLU/mg) of mice treated with
1Eþ07 PVs was set as 100%. *P¼0.004 (Wilcoxon rank sum test, 2 sided).
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susceptibility to infection by HPV11 (Shafti-Keramat et al., 2003),
suggesting it may function as a HPV receptor. However, HPV31
infection of HaCaT cells was not inhibited by heparin or heparinase,
indicating that the role of HSPGs might be cell type if not HPV
genotype speciﬁc (Patterson et al., 2005). In contrast, syndecan-1
was argued to complex with HPV16 and may play a crucial role in
infection (Surviladze et al., 2012). The loss of the activity of
cyclophilins (CyP), especially Cyclophilin B (CyPB) which colocalizes
with syndecan-1, blocks HPV16/18 infection in cells (Bienkowska-
Haba et al., 2009). An interesting ﬁnding indicates that integrin a6b4
interacts and colocalizes with syndecan-1 (Wang et al., 2010). These
ﬁndings complicate the interpretation of a role of integrin a6b4
and/or HSPGs in HPV infection process. In sum, there is consider-
able confusion as to what cellular proteins are important for
HPV infection.
We posit that the differing and in many cases mutually exclusive
conclusions reported in the literature at least in part reﬂect
the choice of cells and culturing conditions used in past studies.
We hypothesize that infection by HPV is mediated by multiple
cellular proteins including integrin a6b4 and syndecan-1. To avoid
the confusion rendered by cell culture studies, we tested our
hypothesis in an animal model that provides us the means for
monitoring early steps of binding and entry by HPV pseudo-
viruses (PVs) in a relevant tissue. If multiple proteins facilitate
HPV infection in vivo, we may not observe a complete disruption
of HPV infection when only a single cellular gene is deleted.
In such circumstances, the efﬁciency of transduction by an HPV
PS must be accessed in a dose-dependent manner to evaluate
the relative importance of candidate proteins. To achieve the goal,
we adapted a mouse model that permits one to monitor trans-
duction by HPV PVs in a relevant tissue, the female reproductive
tract (Roberts et al., 2007). We modiﬁed this in vivo model
to allow us to quantify transduction by HPV16 pseudoviruses
carrying the reporter gene Luciferase. This reﬁned mouse model
permitted us to quantify in vivo reporter gene transduction
by HPV pseudoviruses in a dose-dependent manner, thereby
providing us the means to access cellular requirements using
genetically engineered mouse strains deﬁcient for individual
cellular genes and their gene products that have been previously
implicated in HPV entry in tissue culture studies. Mice condition-
ally deﬁcient for integrin a6b4, or nulligenic for syndecan-1 were
evaluated for their susceptibility to reporter gene transduction by
HPV pseudoviruses.Results
Modiﬁcation of a mouse model for quantifying the efﬁciency of
reporter gene transduction by HPV PVs: a model for assessing genetic
requirements for early steps in papillomavirus infection
To test our hypothesis that multiple cellular proteins mediate
HPV binding/entry together or independently, we ﬁrst modiﬁed a
previously described mouse model for in vivo transduction of
reporter genes by HPV PVs (Roberts et al., 2007). HPV16 PVs
(HPV16:LucF) containing both ﬁreﬂy luciferase and green ﬂuor-
escent protein genes were generated, the titers of these stocks
measured by ﬂow cytometric measurement of GFP-positive cells
exposed to serial dilutions of the PV stock, and then known titers
of PV used to infect reproductive tracts of experimental mice. The
luminescence (luciferase assay) from vaginocervical tissue lysates
were subsequently measured quantitatively as readout for HPV
infection. The relative luminescence units (RLU) per mg total
protein (Bradford protein assay) corresponded to the amount of
HPV16:LucF challenged in mice reproductive tracts (Fig. 1). Ourreﬁned mouse model provides an alternative means to quantify
the efﬁciency of HPV PV gene transduction in vivo, as a means for
assessing genetic requirements for early steps in papillomavirus
infection.
Infectivity of HPV, as scored by PV gene transduction, Is signiﬁcant
reduced in K14Cre/Intb4 f/f mice
Integrin a6b4, restricted primarily to the basal layer of epithe-
lia (Wilhelmsen et al., 2006), has been argued by some but not
other investigators to mediate binding to and possibly the uptake
of papillomavirus particles by cells (Evander et al., 1997;
McMillan et al., 1999). The ﬁnding that laminin 5, the ECM
partner to integrin a6b4, may serve to trap HPV particles to the
ECM (Culp et al., 2006a, 2006b), provides another potential link to
this integrin. This led us to hypothesize that integrin a6b4 in the
relevant tissue may behave differently from what has been
indicated in monolayer tissue culture. It has been proposed that
a non-HSPG receptor is essential for HPV infection (Kines et al.,
2009; Surviladze et al., 2012). That there are interactions between
integrin a6b4 and syndecan-1 and others HSPGs (Wang et al.,
2010) raises the possibility that integrin a6b4 may act indepen-
dently or in conjunction with other cellular proteins in facilitating
HPV infection in vivo. We applied our mouse model to access the
role of integrin a6b4 in HPV infection in vivo by testing whether
the efﬁciency of reporter gene transduction by HPV PVs is
diminished signiﬁcantly in mice deﬁcient for integrin a6b4.
Because of the perinatal lethality resulting from loss of both
alleles of integrin a6 or integrin b4 in the germ line (Raymond et al.,
2005), we examine the requirement of integrin a6b4 for HPV PV
gene transduction in vivo, making use of genetically engineered
mice conditionally deﬁcient for integrin b4 (K14CreIntb4 f/f)
(Raymond et al., 2005) (integrin a6 conditional mice were not
available for study). Cells of skin epithelia from K14CreIntb4 f/f mice
that have undergone Cre-loxP mediated disruption of the condi-
tional allele for integrin b4 also have undetectable levels of integrin
a6. (Raymond et al., 2005). Importantly, there was no compensatory
increase in expression of other integrins in the integrin b4 deﬁcient
cells in vivo (Raymond et al., 2005). We observed that the efﬁciency
of HPV16 PVs gene transduction was modestly but signiﬁcantly
Fig. 2. HPV16 infectivity in integrin a6b4 sufﬁcient verse deﬁcient mice. Intb4 f/f
and K14CreIntb4 f/f mice reproductive tracts (N¼6) were challenged with or
without 3Eþ06 PVs (HPV16:LucF) as indicated. 48 h after infection, mouse female
reproductive tracts were harvested, protein lysates made, and luciferase assays
were carried out to quantify the infectivity. Concentrations of total proteins were
measure by Bradford protein assay. The infectivity level (relative luminescence
units, RLU/mg) of Intb4 f/f mice treated with 3Eþ06 PVs was set as 100%. *P¼0.04
(Wilcoxon rank sum test, 2 sided).
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to that in Intb4 f/f mice (Fig. 2). This same reduction in infection was
observed over 96 h indicating that the reduction in infection was
not simply due to a delay in infection (Fig. S1 supplementary
material). In both the wild type and the integrin conditional null
mice, the luciferase signal decreased over the time course with
maximal expression seen at 48 h. This was as expected because the
rapid turnover of epithelial cells in the female reproductive tract
results in sloughing off of infected cells by 72–96 h. By 120 h a
difference in luciferase signal between the wild type and integrin
conditional null mice was no longer observed and the level of
luciferase activity was low in both strains, presumably reﬂective of
the epithelial cell turnover. These data support the hypothesis that
integrin a6b4 contributes quantitatively, but perhaps not qualita-
tively, to the efﬁciency of HPV infection in vivo.
HPV PVs transduce reporter genes in portions of mouse female
reproductive tract epithelia having little-to-no detectable levels of
integrin a6
In the original study describing the phenotypes of the
K14creIntb4 f/f mice in skin epithelia, it was observed that not all
epithelial cells lost expression of integrin b4, and this correlated
with retention of expression of integrin a6 (Raymond et al., 2005).
To learn whether this is also the case in the female reproductive
tract and to learn if HPV pseudoviruses selectively transduce
those portions of the reproductive tract deﬁcient for integrin
expression, we performed integrin a6-speciﬁc immunoﬂuores-
cence on K14creIntb4 f/f mice.
In the female reproductive tract epithelia, Intb4 f/f mice express
integrin a6 consistently in basal cells (Fig. 3A); whereas, K14creIntb4 f/f
mice lose expression of integrin a6 with patches of integrin a6-
negative tissue interdigitated between patches of integrin a6-positive
tissue (Fig. 3B). This is consistent with what was observed in the skin
of this same mouse genotype (Raymond et al., 2005). To look at
susceptibility of integrin a6-positive versus integrin a6-negative tissue
to HPV PV-mediated gene transduction, K14creIntb4 f/f and Intb4 f/f
mice were exposed to HPV16:TWB PVs carrying the tdTomato gene
and 72 h post-exposure reproductive tracts were snap frozen, sec-
tioned, stained with antibodies to integrin a6 and analyzed by
ﬂuorescence microscopy. We observed that most epithelial cells inthe reproductive tract of the Intb4 f/f mice express integrin a6 in
basementmembrane and displayed robust tdTomato signal indicative
of infection (Fig. 3A). The tdTomato-positive cells were conﬁrmed to
be of epithelial origin by staining for Keratin 14, a marker for
epithelial cells (Fig. 3C). In the K14CreIntb4 f/f mice, we observed that
most of the tdTomato positive epithelia accompany positive staining
for integrin a6; however, there were clearly tdTomoato red positive
cells in regions without detectable levels of integrin a6. From these
observations, we conclude that cellular integrin a6b4 is not absolutely
required for HPV infection in vivo, though it appears to inﬂuence the
efﬁciency of infection.Syndecan-1, the predominant HSPG in epithelial cells, is not necessary
for HPV infection in vivo, based upon PV gene transduction studies
To address whether syndecan-1 is required for HPV infection,
we ﬁrst conﬁrmed the binding of HPV16 PVs to mouse syndecan-
1 by immunoprecipitation in mouse C127 cells (Fig. S2 supple-
mentary material), and then monitored the efﬁciency of HPV PV -
mediated gene transduction in syndecan-1 null mice. The efﬁ-
ciency of HPV PV-mediated gene transduction was not signiﬁ-
cantly different in syndecan-1-sufﬁcient versus -null mice by
monitoring the level of luciferase expression in extracts of female
reproductive tracts of mice exposed to HPV16:Lucf PVs (Fig. 4).
We also observed the same results when using HPV31 and HPV45
PVs (Fig. S3 supplementary material). These results argue that
syndecan-1 is not essential for HPV infection in this mouse model.
However, because carrageenan did inhibit in vivo HPV PV-
mediated gene transduction in our hands (Fig. 1) as reported by
others (Roberts et al., 2007), this raises the likelihood that other
HSPGs can mediate infection in the absence of syndecan-1.Discussion
Based upon our in vivo studies, we conclude that neither
integrin a6b4 nor syndecan-1, two putative cell surface receptors
for papillomaviruses are absolutely required for gene transduction
of the mouse female reproductive tracts by HPV pseudoviruses.
These results provide a strong rationale for pursuing the identiﬁca-
tion of alternative cell surface receptors for HPVs. One obvious
possibility, in the case of syndecan-1 null mice, is that other HSPGs
can serve as replacement receptors for syndecan-1. Earlier studies
documented compensatory increases in other HS-modiﬁed pro-
teins (Liu et al., 2003), and the surface expression of integrins
(Stepp et al., 2007) in syndecan-1 null keratinocytes. Thus an
obvious route of further study is to look at the possible role of these
proteins that might also be increased in their expression in the
female reproductive tracts of syndecan-1 null mice. That carragee-
nan is an effective inhibitor of HPV pseudovirus infection in the
mouse female reproductive tract argues that HSPGs are important
for HPV infection in this mouse model (Fig. 1) (Roberts et al., 2007).
On the other hand, compensation is not likely to be an
explanation for the retention of infectivity in areas of the female
reproductive tract of K14CreIntb4 f/f mice that fail to express
detectable integrin a6, as no compensatory increases in other
integrins have been detected in these mice (Raymond et al.,
2005). Also, the fact that integrin a6 was lost in the female
reproductive tract of K14CreIntb4 f/f mice would argue that no
alternative integrin a6 partner is induced, for, were a partner
induced in its expression, then levels of integrin a6 would not
have decreased. This leaves us to question the absolute necessity
for any integrin in mediating HPV infection in vivo in this mouse
model, even though there clearly is a quantitative reduction in
infection in the K14CreIntb4 f/f mice.
Fig. 3. HPV16 PVs infection in the reproductive tract epithelia of integrin a6b4 sufﬁcient verse deﬁcient mice. Intb4 f/f and K14CreIntb4 f/f mice reproductive tracts were
challenged with 1Eþ07 PVs (HPV16:TWB). 72 h after infection, mouse female reproductive tracts were harvested, snap frozen, cryosection made, DAPI staining (blue) for
cell nuclei and tdTomato red ﬂuorescence (red) indicated as viral infection were monitored by microscopy. (A) HPV16 PVs infection in Intb4f/f mice; FITC (green) indicates
the immunohistochemistry staining for integrin a6 (B) HPV16 PVs infection in K14CreIntb4 f/f mice; FITC (green) indicates the immunohistochemistry staining for integrin
a6 (C) HPV16 PVs infection in Intb4 f/f mice; FITC (green) indicates the immunohistochemistry staining for Keratin14.
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cellular requirements for HPV infection, and points to their use in
assessing the role of other cellular factors in mediating HPV
infection. Our and others’ previous studies (Huang et al., 2010;
Karanam et al., 2010) demonstrated that the strong antiviral
activity of gamma secretase inhibitors both in vitro and in vivo.
Gamma secretase is known to cleave a number of cell surface
molecules including growth factor receptors (Kopan and Ilagan,
2004). One or more of these cell surface targets of gamma secretase
may prove to be essential cell surface receptors for HPV infection.The availability of genetically engineered strains of mice deﬁcient
in these cellular genes provides a basis for deﬁnitive future studies.Material and methods
Plasmids
p16SheLL, p31SheLL, and p45SheLL (10.8 kilo base pair
plasmids and too large to be packaged in HPV VLPs) that express
Fig. 4. HPV16 infectivity in int-1 -sufﬁcient versus -null mice. Non-transgenic
(syndecan-1-sufﬁcient) and syndecan-1 null mice reproductive tracts (N¼6) were
challenged with or without 2.5Eþ06 PVs (HPV16:LucF) as indicated. 48 h after
infection, mouse female reproductive tracts were harvested, protein lysates made,
and luciferase assays were carried out to quantify the infectivity. Concentrations
of total proteins were measure by Bradford protein assay. The infectivity level
(relative luminescence units, RLU/mg) of non-transgenic mice treated with
2.5Eþ06 PVs was set as 100%. *P¼0.87 (Wilcoxon rank sum test, 2 sided).
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pLucF, that encodes both ﬁreﬂy luciferase (Luc) and green
ﬂuorescent protein (GFP). pTWB, that encodes red ﬂuorescent
protein (tdTomato). These plasmids are gifts from Dr. Christopher
Buck in National Cancer Institute.
Cell cultures
293FT cells expressing enhanced SV40 large T antigen (Invi-
trogen) were maintained in DMEM medium (high glucose)
(Invitrogen) containing 10% fetal bovine serum (Harlan) supple-
mented with 0.1 mM MEM non-essential amino acids (Invitro-
gen), 1 mM sodium pyruvate (Invitrogen), 2 mM L-glutamine
(Invitrogen) and 500 ug/ml Geneticin. Mouse C127 cells were
cultured in DMEM medium containing 10% fetal bovine serum.
Antibodies
Rat anti-human integrin a6 antibody conjugated with ﬂuor-
escein isothiocyanate (FITC), GoH3 (Serotec), Rabbitt-antimouse
keratin14 antibody conjugated with FITC (Covance/BAbCO), Mouse
anti-HPV16 L1 antibody (Abcam, ab69), Mouse anti-syndecan-1
antibody (Santa Cruz) and Goat anti-mouse HRP light chain
(Jackson Immunoresearch).
Generation of HPV16 pseudoviruses (PVs)
HPV virus-like particles (VLPs) carrying encapsidated reporter
plasmids are referred in the papilomavirus ﬁeld as HPV pseudo-
viruses (PVs). Reporter pseudovirions were produced using
previously-described methods (Buck et al., 2004; Buck and
Thompson, 2007). Brieﬂy, two plasmids expressing HPV16 L1/L2
capsids proteins and reporter genes respectively were cotrans-
fected into 293FT cells to generate HPV16 pseudovirions,
HPV16:LucF or HPV16:TWB. Pseudovirions were harvested by
detergent lysis of the cells 48 h after transfection. Particles were
allowed to mature overnight (Buck et al., 2005) and were puriﬁed
by ultracentrifugation through OptiPrep Density Gradient Med-
ium (Sigma). The titers of HPV16 PVs were determined by ﬂow
cytometric analysis of 293FT cells treated with various dilutionsof puriﬁed pseudovirion stock. Alternatively, HPV31 and HPV45
PVs were generated as described as above.
Mouse model for quantifying the in vivo efﬁciency of HPV infection
HPV:LucF pseudoviruses were used to establish a quantitative
mouse infection model for HPV in the female reproductive tract.
The method is a modiﬁed version of a previously published model
(Roberts et al., 2007). Indicated numbers of HPV:LucF PVs were
delivered intravaginally in 4% carboxyl methyl cellulose (Sigama
Cat. #C4888) using 6–8 weeks old virgin female mice. The mice
were prepared by subcutaneous injection with 3 mg medroxy-
progesterone acetate (Sicor, Depo-Provera ) 4 day prior pseudo-
virus challenge to induce diestrus. 6 h prior to PVs instillation, the
mice were pre-treated vaginally with Conceptrol (Caldwell Con-
sumer Health), an over the counter spermicide product containing
4% nonoxynol-9. Administration of nonoxynol-9 has previously
been shown to potentiate HPV PVs infection due to chemical
injury of the vaginal/cervical epithelium (Roberts et al., 2007).
48 h after delivery of the PVs, mouse female reproductive tracts
were harvested, homogenized in lysis buffer for luciferase assay
by a tissue homogenizer (PowerGen 125, Fisher Scientiﬁc), and
soluble tissue lysates were used to quantify the efﬁciency of
infection by luciferase assay as per the manufacturer (Promega,
Cat. #1501 and #1531).
Bradford protein assay
The amount of total proteins in reproductive tissue lysates
used for luciferase assay was measured by Bradford protein assay
(Bio-Rad Protein Assay Dye reagent Concentrate, Cat. #500-0006).
The infectivity of PVs is indicated as relative luminescence units
(RLU) per mg.
A time course of HPV16 infection in integrin a6 sufﬁcient verse
deﬁcient mice
Intb4 f/f and K14CreIntb4 f/f mice reproductive tracts were chal-
lenged as described as above with or without 3Eþ06 HPV16:LucF
PVs. Mouse female reproductive tracts were harvested at 48, 72,
96, and 120 h post infection, protein lysates made, and luciferase
assays were carried out to quantify the infectivity. Concentrations
of total proteins were measure by Bradford protein assay.
Cell susceptibility for HPV16 infection in integrin a6b4 sufﬁcient verse
deﬁcient mice
Alternatively, experiments describe above were repeated using
1Eþ07 HPV16:TWB PVs in Intb4 f/f and K14CreIntb4 f/f mice. 72 h
after delivery of the PVs, mouse female reproductive tracts were
harvested, snap frozen, cryosection made, and tdTomato red
ﬂuorescence expression indicated as viral infection were mon-
itored by microscopy (Axiovert 200M, Carl Zeiss Microimiaging).
Immunohistochemistry staining for integrin and keratin 14
Mouse female reproductive tracts infected with HPV16:TWB
were collected, embedded in cryoprotectant (Tissue-Tek O.C.T.,
Sakura Finetek Europ, Zoeterwoude, The Netherlands). Cryosec-
tions were prepared, ﬁxed in ice-cold acetone, and blocked in PBS
with 5% Bovine Serum Albumin (BSA, A2153, Sigma) or 5% horse
serum (H0146, Sigma) for one hour at room temperature. Cryo-
sections are then incubated with 1:100 dilution of primary Ab
conjugated with FITC in blocking solution at 4 1C overnight. Slides
mounting medium with 4’-6-Diamidino-2-phenylindole (DAPI)
(Vectashield, hard set, H-1500, Vector Laboratories) was used for
H.-S. Huang, P.F. Lambert / Virology 433 (2012) 395–400400cell nuclei staining. Fluorescence images were taken by Carl Zeiss
microscopy.
Immunoprecipitation (IP)/Westerns
1Eþ07 mouse C127 cells were exposed to 1Eþ08 HPV16 PVs
(10 M.O.I.) for 4 h, and then treated or untreated (Mock Infection)
with water-soluble cross-linker (1 mM DTSSP, Thermo Scientiﬁc)
in cold PBS and incubated for 30 min at 4 1C. Cells were washed
three times with cold PBS and quenched with 50 mM Tris pH
7.5 for 15 min at 4 1C. Cell were washed three times with cold PBS
and solubilized with 1ml cold lysis buffer (1% TX100, 50 mM Tris–
HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM PMSF, 10 ng/ml
leupeptin, 10 ng/ml aprotinin). Save soluble proteins in super-
natants by centrifugation at 13,000 rpm for 10 min. Add mouse
anti HPV16 L1 antibody with protein A-agarose (Thermo Scien-
tiﬁc, Pierce) beads for 1 h at 4 1C. Beads were washed twice with
cold lysis buffer, resuspended in 20 ul Laemmli sample buffer and
boiled for 5 min. Solubilized proteins were resolved by 12% SDS-
PAGE (Boi-Rad) and were electroblotted onto PVDF membranes.
Membranes were blocked, and probed with primary antibodies
(mouse anti-HPV16 L1 or anti-syndecan-1) and anti-mouse sec-
ondary antibody. Antibody/protein complexes on blots were detected
using enhanced chemiluminescence (Amersham Biosciences).
HPV infections in syndecan-1 sufﬁcient verse null mice
Alternatively, experiments describe above were repeated using
2.5Eþ06 HPV16:LucF/HPV31:LucF/HPV45:LucF PVs in non-
transgenic (syndecan-1 sufﬁcient) and syndecan-1 null mice.
Mouse female reproductive tracts were harvested at 48 h post
infection, protein lysates made, and luciferase assays were carried
out to quantify the infectivity. Concentrations of total proteins
were measure by Bradford protein assay.Appendix A. Supplementary material
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.virol.2012.08.032.References
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